David Watson - 21 Apr 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
General Counsel
Signature
/s/ David Watson
Issuer symbol
APLS
Transactions as of
21 Apr 2023
Transactions value $
$0
Form type
4
Filing time
24 Apr 2023, 16:20:30 UTC
Previous filing
22 Feb 2023
Next filing
29 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Gift $0 -67,955 -38.84% $0 107,013 21 Apr 2023 Direct
transaction APLS Common Stock Gift $0 +67,955 $0 67,955 21 Apr 2023 Indirect Owner (The David O. Watson Irrevocable Trust of 2023) F1
holding APLS Common Stock 3,333 21 Apr 2023 Indirect Owner (Custodial Account for Son) F2
holding APLS Common Stock 6,667 21 Apr 2023 Indirect Owner (The Watson Education Trust) F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 21, 2023, the reporting person transferred 67,955 shares to The David O. Watson Irrevocable Trust of 2023. William Zorn is the trustee of The David O. Watson Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The David O. Watson Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
F2 This represents a custodial account held by the reporting person for the sole benefit of his minor son.
F3 The securities are held by The Watson Education Trust, for which the reporting person serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Watson Education Trust except to the extent of his pecuniary interest therein.